Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio Stock Drops After Singapore Collaboration for HiFi Sequencing
12:07pm, Thursday, 12'th Sep 2024
PACB's HiFi sequencing powers the HiFi Consortium's global effort to enhance the diagnosis and treatment of subfertility and recurrent pregnancy loss.
LOS ANGELES, CA / ACCESSWIRE / September 12, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
01:40pm, Wednesday, 11'th Sep 2024
PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
PacBio's Stock Up on Munster Deal for Male Infertility Research
12:30pm, Wednesday, 11'th Sep 2024
PACB collaborates with the University Hospital of Munster, using Revio HiFi sequencing to advance research on male infertility and rare diseases in Germany and globally.
Investors Are Encouraged To Assist The Schall Law Firm Investigate Whether Pacific Biosciences Of California, Inc. Violated Securities Laws
11:00am, Wednesday, 11'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
09:05am, Wednesday, 11'th Sep 2024
Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Treatment of Subfertility and Recurrent Pregnancy Loss Collaboration Aims to Harness HiFi Sequencing to Improve Diagnosis and Tre
LOS ANGELES, CA / ACCESSWIRE / September 10, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Bios
LOS ANGELES, CA / ACCESSWIRE / September 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
LOS ANGELES, CA / ACCESSWIRE / September 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
LOS ANGELES, CA / ACCESSWIRE / September 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
Pacific Biosciences Of California Inc Is Being Investigated For Fraudulent Actions And The Schall Law Firm Seeks Shareholder Participation
11:00am, Wednesday, 04'th Sep 2024
LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
09:05am, Wednesday, 04'th Sep 2024
Highly Accurate Long-Read Sequencing Data from Revio will Support Germany's National Genome Initiative and Provide Data to the International Male Infertility Consortium Highly Accurate Long-Read Seque
LOS ANGELES, CA / ACCESSWIRE / September 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
LOS ANGELES, CA / ACCESSWIRE / September 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Pacific Biosc
